NASDAQ:TRPX - THERAPIX BIOSCI/S Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.78 -0.12 (-3.08 %)
(As of 01/22/2019 09:45 AM ET)
Previous Close$3.90
Today's Range$3.78 - $3.90
52-Week Range$3.00 - $9.30
Volume1,377 shs
Average Volume49,875 shs
Market Capitalization$13.64 million
P/E Ratio6.84
Dividend YieldN/A
Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include THX-110 for the treatment of Tourette syndrome, Obstructive Sleep Apnea, and pain; THX-130 for the treatment of Mild Cognitive Impairment and Traumatic Brain Injury; THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain. Therapix Biosciences Ltd. has a product development agreement with Cure Pharmaceutical to develop cannabinoid-based product for sleep disorders. The company was formerly known as NasVax Ltd. and changed its name to Therapix Biosciences Ltd. in November 2013. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel.

Receive TRPX News and Ratings via Email

Sign-up to receive the latest news and ratings for TRPX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:TRPX



Sales & Book Value

Annual SalesN/A
Cash Flow$1.75 per share
Book Value$2.42 per share


Net Income$-6,240,000.00


Market Cap$13.64 million
OptionableNot Optionable

THERAPIX BIOSCI/S (NASDAQ:TRPX) Frequently Asked Questions

What is THERAPIX BIOSCI/S's stock symbol?

THERAPIX BIOSCI/S trades on the NASDAQ under the ticker symbol "TRPX."

How were THERAPIX BIOSCI/S's earnings last quarter?

THERAPIX BIOSCI/S (NASDAQ:TRPX) announced its quarterly earnings data on Monday, December, 3rd. The company reported ($0.50) earnings per share for the quarter. View THERAPIX BIOSCI/S's Earnings History.

When is THERAPIX BIOSCI/S's next earnings date?

THERAPIX BIOSCI/S is scheduled to release their next quarterly earnings announcement on Monday, April 29th 2019. View Earnings Estimates for THERAPIX BIOSCI/S.

Has THERAPIX BIOSCI/S been receiving favorable news coverage?

News stories about TRPX stock have trended very positive on Tuesday, InfoTrie reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. THERAPIX BIOSCI/S earned a coverage optimism score of 3.2 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are some of THERAPIX BIOSCI/S's key competitors?

Who are THERAPIX BIOSCI/S's key executives?

THERAPIX BIOSCI/S's management team includes the folowing people:
  • Dr. Ascher Shmulewitz, Chairman & Interim CEO (Age 63)
  • Dr. Adi Zuloff-Shani, Chief Technology Officer (Age 51)
  • Mr. Oz Adler CPA, Chief Financial Officer (Age 33)

How do I buy shares of THERAPIX BIOSCI/S?

Shares of TRPX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is THERAPIX BIOSCI/S's stock price today?

One share of TRPX stock can currently be purchased for approximately $3.78.

How big of a company is THERAPIX BIOSCI/S?

THERAPIX BIOSCI/S has a market capitalization of $13.64 million. THERAPIX BIOSCI/S employs 12 workers across the globe.

What is THERAPIX BIOSCI/S's official website?

The official website for THERAPIX BIOSCI/S is

How can I contact THERAPIX BIOSCI/S?

THERAPIX BIOSCI/S's mailing address is 4 Ariel Sharon StreetHaShahar Tower 16th Floor, Givatayim L3, 5320047. The company can be reached via phone at 972-3616-7055.

MarketBeat Community Rating for THERAPIX BIOSCI/S (NASDAQ TRPX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  182 (Vote Outperform)
Underperform Votes:  175 (Vote Underperform)
Total Votes:  357
MarketBeat's community ratings are surveys of what our community members think about THERAPIX BIOSCI/S and other stocks. Vote "Outperform" if you believe TRPX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRPX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2019 by Staff

Featured Article: Reverse Stock Split

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel